OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
Cochlear, a provider of implantable hearing solutions, has obtained an approval from the US Food and Drug Administration (FDA) for the Cochlear Baha 4 attract system for use in the US. The new Baha 4 attract system is a magnetic Baha bone ...
US-based Konica Minolta Medical Imaging has announced the launch of Sonimage P3 hand-held ultrasound device. Sonimage P3 represents the first product in the company's business strategy to accelerate growth and expand solutions in the ...
Bolton Medical, a medical device manufacturer, has initiated its Phase II US clinical trial to study the safety and effectiveness of the Treovance abdominal stent-graft with Navitel delivery system. The first two cases were performed on ...
Under pressure from the FDA, 23andMe says it will stop selling health-related genetic test analysis until it has resolved its dispute with the federal regulatory agency. "We remain firmly committed to fulfilling our long-term mission to ...
Minimally invasive medical device specialist Angiodynamics (Albany, NY) has announced its intention to cut as many as 100 of its workers, representing nearly 8% of its workforce of approximately 1330. The move is part of what the firm terms ...
The difference between the healthiest diets and the least healthy diets is $1.50 a day, U.S. researchers found. Lead author Mayuree Rao, a junior research fellow in the Department of Epidemiology at the Harvard School of Public Health, ...
Tags: Agriculture, Food, Health, Medicine
US-based Sense4Baby has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its smartphone-based maternal/fetal monitoring system. The company has also obtained CE Mark approval from the European Commission for its ...
PrimeraDx, a molecular diagnostics company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its ICEPlex C. difficile assay kit and the ICEPlex system. The ICEPlex system is a multiplex real-time PCR system ...
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
Biogen Idec announced that the US Food and Drug Administration (FDA) has extended its review of a marketing application for the long-lasting recombinant factor IX Fc fusion protein Alprolix for haemophilia B by three months. The company ...
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
PharmAthene, a biodefense company, announced that it has terminated its definitive merger agreement with US-based Theraclone Sciences with consent from Theraclone. The agreement provided for the merger of a wholly-owned subsidiary of ...